L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial - Wikidata - wikimedia - TriplyDB

L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial

L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial

http://www.wikidata.org/entity/Q36226621

about

Nutrition in Pancreatic Cancer: A Review Micronutrients in Oncological Intervention The Pancreas: Causes for Malabsorption Cachexia and pancreatic cancer: are there treatment options?A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project Pancreatic cancer cachexia: a review of mechanisms and therapeutics.An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status.Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy Early Parenteral Nutrition in Patients with Biliopancreatic Mass Lesions, a Prospective, Randomized Intervention Trial Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial).Current pharmacotherapy options for cancer anorexia and cachexia.Advances in pharmacologic strategies for cancer cachexia.Cancer-induced muscle wasting: latest findings in prevention and treatment.Update on Management of Cancer-Related Cachexia.Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis.Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma.

P2860

Q26741097-FA3CF5A8-230B-45A6-B377-CE389C89085F Q26764839-20698A47-644B-4E4B-B0E1-F602408F56D3 Q26866465-78719B36-8E86-415C-86B9-F24EA2724473 Q27026558-111E67B7-F00D-42A4-A401-78ECA1A31D25 Q28071927-151EA682-01CF-433E-BC50-08F4BECA9FB8 Q34660312-D55D55E6-29E9-4C5A-A1B7-7EF394622FE3 Q34672667-038135A4-70B1-47F8-AA24-2CAC5B6A21CB Q34685307-5A65E8DF-B259-4D1E-B578-91F94ABEFEEF Q35565254-9D964724-F722-4A57-9FAE-4CE2B91177F8 Q36197291-E9862FD0-DC83-4DE7-A484-55EF51546DB8 Q37057905-B863491F-4EBD-4E20-A733-B2DD499E9E23 Q38052613-C67DC797-9440-432D-B8C9-766492966046 Q38578582-B174F7C9-0FF4-40E7-85DF-CCEDC534B637 Q38681113-9D1E2D4C-E163-4FFF-91CF-7A87FB43F763 Q38990581-B1569033-6E2E-4DC5-94F8-D468863B1327 Q47103663-4C5B35BA-FA27-4C2A-B9D3-564302F30B30 Q47547107-981CE98E-8793-49C4-A7E7-9DB7F272EC44

P2860

L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial

http://www.wikidata.org/entity/Q36226621

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

L-Carnitine-supplementation in ...... a randomized multicentre trial

@ast

L-Carnitine-supplementation in ...... a randomized multicentre trial

@en

type

label

L-Carnitine-supplementation in ...... a randomized multicentre trial

@ast

L-Carnitine-supplementation in ...... a randomized multicentre trial

@en

prefLabel

L-Carnitine-supplementation in ...... a randomized multicentre trial

@ast

L-Carnitine-supplementation in ...... a randomized multicentre trial

@en

P1433

Q36226621-5A779B44-EC47-44A8-8F5D-06055032A8C4

P1476

Q36226621-59D87853-B27C-4694-A933-79F41F8B8C90

P2093

Q36226621-060EC50A-FB03-4D47-AC5F-4441975652AE

Q36226621-08FE4AAA-821F-4902-93D0-BF57FC3755ED

Q36226621-147D4F06-5B93-4146-8E84-13DDFE766710

Q36226621-1BF68404-C5CF-45F6-B60E-4B34DB9586AD

Q36226621-238A14A5-B56A-4309-9914-0B11A9459A47

Q36226621-482777D1-020D-4195-A9C8-C5ADEDF74867

Q36226621-4A3AD585-6641-4545-868E-67D6CC2068C4

Q36226621-516B89C9-4656-4B20-8F6D-E6E033DD79D0

Q36226621-5D02B323-61FB-47B7-BD29-E2DA571C44EB

Q36226621-81AF71D1-9FD8-4AD3-B016-A4DFE6CC27E7

P2860

Q36226621-0A506E4B-A5D5-4218-B024-00A13C463301

Q36226621-0B31F6C9-8E49-4415-8B79-21D515621D61

Q36226621-0E0D56F8-842E-4616-AF1B-23A5478EB71C

Q36226621-0EC6EA24-1E77-46DE-9A15-A572D1F82D0B

Q36226621-2092F859-62A5-4456-B674-9D121019D979

Q36226621-35C04968-A4FD-4E3A-AA97-703CD0F53AF3

Q36226621-46EBE9BC-541A-41AC-9EB8-F262AE92B5CD

Q36226621-4B7E70F3-139E-45F6-BC88-92CC7563AE3D

Q36226621-70930815-783E-49AB-91E0-C7DE934384E9

Q36226621-79F8CD8C-196D-4E12-82EB-6A6ABAA15959

P2888

Q36226621-A3F333B6-4E0E-4813-A198-837D26CD5918

P304

Q36226621-752D9B41-8B79-4AF2-8701-A3FD357AE7A5

P31

Q36226621-DAD47048-7074-46E6-94EE-324AD5C78B4E

P356

Q36226621-A4B5A0FC-367B-4FA6-831B-AED58B53DA15

P478

Q36226621-5B828143-FDF6-4E8E-9AA6-BCC16A489FA0

P50

Q36226621-B24405E4-9CBF-46C5-9265-461BF59B231B

Q36226621-BF9B1C6F-565B-490F-A454-ED51CE03DE88

P577

Q36226621-91572629-E6A5-4A9F-A682-D546B19BF9B5

P5875

Q36226621-C90978A2-6AB0-4068-92DA-7AB57EE3B349

P6179

Q36226621-56260B68-FDBD-416F-85B9-53AF68A6676A

P698

Q36226621-2AC013AE-5AE4-4250-9992-8FEC60292670

P921

Q36226621-8D2FECFC-4ACF-46C1-A3FE-80A5B18DD59E

P932

Q36226621-32AEE572-259A-4ACF-B963-6574C171F2BE

P356

1475-2891-11-52

P1433

Nutrition Journal

P1476

L-Carnitine-supplementation in ...... a randomized multicentre trial

@en

P2093

Ali Aghdassi

http://www.w3.org/2001/XMLSchema#string

Claudia Nitsche

http://www.w3.org/2001/XMLSchema#string

Cornelia Müller

http://www.w3.org/2001/XMLSchema#string

Eckhard Weber

http://www.w3.org/2001/XMLSchema#string

Georg Engel

http://www.w3.org/2001/XMLSchema#string

Heide Koula-Jenik

http://www.w3.org/2001/XMLSchema#string

Jens Stieler

http://www.w3.org/2001/XMLSchema#string

Kathleen Kraft

http://www.w3.org/2001/XMLSchema#string

Kerstin Schütte

http://www.w3.org/2001/XMLSchema#string

Maciej Patrzyk

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2001

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function

Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association.

Nutritional support of the cancer patient: issues and dilemmas.

Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia.

New directions in the management of advanced pancreatic cancer: a review.

Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.

P2888

1475-2891-11-52

P304

52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2891-11-52

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Peter Malfertheiner

P577

2012-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229551954

http://www.w3.org/2001/XMLSchema#string

P6179

1050173499

http://www.w3.org/2001/XMLSchema#string

P698

22824168

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

3439338

http://www.w3.org/2001/XMLSchema#string